Quercetin‑induced renal stone - Symptoms, Causes, Treatment & Prevention

```html

Overview

Quercetin is a plant‑derived flavonoid found in apples, onions, berries, and many dietary supplements marketed for its antioxidant and anti‑inflammatory properties. While generally safe at typical food‑intake levels, high‑dose quercetin supplementation (often >500 mg per day) has been linked in rare case reports to the formation of kidney stones – a condition we refer to as quercetin‑induced renal stone.

Renal stones (nephrolithiasis) are solid mineral deposits that develop within the kidney’s collecting system. When quercetin is metabolized, it can precipitate as a quercetin‑derived calcium oxalate or uric acid crystal under certain urinary conditions (high concentration, low pH, reduced citrate). The resulting stone behaves like any other kidney stone but may have a distinct chemical signature on laboratory analysis.

Who it affects: Most reported cases involve adults 30‑65 years old who use high‑dose quercetin supplements for bodybuilding, immune support, or chronic inflammation. A slight male predominance (≈60 %) has been noted, mirroring the overall epidemiology of kidney stones.

Prevalence: Quercetin‑induced stones are extremely rare. Large cohort studies of supplement users (n ≈ 25,000) have identified < 0.02 % incidence, far lower than the overall lifetime risk of kidney stones (≈ 10 % in men, 7 % in women) reported by the NIH National Institute of Diabetes and Digestive and Kidney Diseases. Nevertheless, awareness is important because the condition can be misdiagnosed as “idiopathic” stone disease, delaying targeted prevention.

Symptoms

Symptoms of a quercetin‑induced stone are indistinguishable from those caused by other types of renal calculi. Common manifestations include:

• Flank or back pain: Sudden, severe (often “colicky”) pain that may radiate to the groin.
• Hematuria: Pink, red, or tea‑colored urine from microscopic to gross bleeding.
• Urgent or frequent urination: Sensation of needing to void despite a small urine volume.
• Nausea & vomiting: Triggered by pain or autonomic reflexes.
• Fever & chills: May indicate infection superimposed on a stone (needs urgent evaluation).
• Side‑flank tenderness on physical exam.
• Reduced urine output if the stone obstructs the ureter completely.

In rare cases, patients report fluid‑filled “cloudy” urine after taking quercetin, which can be an early clue when coupled with high supplement dosages.

Causes and Risk Factors

Mechanism of stone formation

Quercetin itself is not a typical stone constituent, but its metabolites can act as nucleation sites for calcium oxalate or uric acid crystals:

1. High urinary concentration – Large oral doses exceed intestinal absorption, leading to elevated plasma levels and subsequent renal excretion.
2. Acidic urine pH – Quercetin metabolites are more likely to precipitate when urine pH < 5.5.
3. Low urinary citrate – Citrate normally binds calcium; depletion (common in high‑protein diets) removes this protective effect.
4. Oxalate load – Quercetin metabolism can increase oxalate generation, a known risk factor for calcium oxalate stones.

Individual risk factors

• Daily quercetin supplement ≥ 500 mg (especially without medical supervision).
• History of prior kidney stones.
• Low fluid intake (< 2 L/day).
• High‑protein, low‑carbohydrate diets (ketogenic, paleo) that lower urinary citrate.
• Obesity (BMI ≥ 30 kg/m²) – increases urinary acidity.
• Metabolic conditions: hyperuricosuria, hyperoxaluria, hypercalciuria.
• Use of other supplements that raise oxalate (e.g., vitamin C megadoses).

Diagnosis

Because the clinical picture mirrors other stone types, a systematic work‑up is required.

Initial assessment

1. History – Detailed supplement intake (dose, brand, duration), diet, fluid habits, prior stones.
2. Physical exam – Flank tenderness, costovertebral angle (CVA) percussion.
3. Urinalysis – Look for hematuria, infection, pH, and crystalluria.

Imaging studies

• Non‑contrast CT scan of the abdomen/pelvis – Gold standard; detects stones as small as 1‑2 mm.
• Ultrasound – Useful in pregnancy or when radiation avoidance is preferred; less sensitive for tiny stones.
• Plain abdominal X‑ray (KUB) – Detects radiopaque stones but many quercetin‑related stones are radiolucent.

Stone analysis

If a stone is passed or surgically removed, it should be sent to a specialized laboratory for infrared spectroscopy or X‑ray diffraction. Identification of quercetin‑related organic matrix or a distinctive calcium‑oxalate pattern with flavonoid traces confirms the diagnosis.

Metabolic work‑up

Performed after the acute episode resolves (typically 4‑6 weeks later):

• 24‑hour urine collection (calcium, oxalate, citrate, uric acid, creatinine, volume).
• Serum studies: calcium, phosphate, uric acid, creatinine, fasting glucose.

Treatment Options

Acute stone management

• Hydration – Aim for > 2.5 L urine output per day; intravenous fluids if oral intake is limited.
• Pain control – NSAIDs (e.g., ibuprofen 600 mg q6‑8h) are first line; avoid nephrotoxic NSAIDs in severe renal impairment.
• Medical expulsive therapy (MET) – Alpha‑blocker (tamsulosin 0.4 mg daily) can aid passage of stones < 10 mm in the distal ureter.
• Antibiotics – If fever, positive urine culture, or sepsis is present (e.g., ceftriaxone 1‑2 g IV q24h).

Procedural interventions

When stones are > 10 mm, fail to pass, or cause obstruction/infection, consider:

1. Extracorporeal shock wave lithotripsy (ESWL) – First‑line for most renal stones < 2 cm.
2. Ureteroscopy with laser lithotripsy – Preferred for distal ureteral stones or when ESWL fails.
3. Percutaneous nephrolithotomy (PCNL) – Reserved for large (> 2 cm) or staghorn calculi.

Long‑term prevention (specific to quercetin‑induced stones)

• Stop or reduce quercetin supplementation – Typically discontinue doses > 500 mg/day.
• Alkali therapy – Citrate salts (potassium citrate 10‑20 mEq 2–3×/day) raise urinary pH and bind calcium.
• Thiazide diuretics – For hypercalciuria, low‑dose thiazide (e.g., hydrochlorothiazide 12.5‑25 mg daily) reduces urinary calcium.
• Allopurinol – If uric acid is elevated.
• Dietary counseling – Emphasize adequate fluids, moderate animal protein, low‑oxalate foods, and regular calcium intake (≈ 1000 mg/day).

Living with Quercetin‑Induced Renal Stone

Managing the condition involves both medical and lifestyle adjustments.

• Hydration strategy – Carry a 1‑L water bottle; sip regularly. Add a pinch of salt and citrus flavor to encourage intake.
• Track supplement use – Keep a written log of all vitamins, herbal products, and dosages.
• Urine monitoring – Test strips for pH; aim for 6.0–7.0.
• Regular follow‑up – 6‑month urine studies and imaging if you have a history of recurrent stones.
• Exercise – Moderate activity improves bone turnover and helps maintain a healthy weight, reducing stone risk.
• Stress management – Chronic stress can increase catecholamines that affect calcium metabolism; yoga or mindfulness can be beneficial.

Prevention

1. Moderate quercetin intake – Stay below 500 mg/day unless prescribed by a clinician.
2. Maintain urine output ≥ 2 L/day – Use a fluid diary during hot weather or intense exercise.
3. Consume citrate‑rich beverages – Lemon or orange juice (½ cup) with each main meal.
4. Limit high‑oxalate foods – Spinach, rhubarb, beet greens, nuts (if you have hyperoxaluria).
5. Balanced diet – 45‑55 % carbs, 15‑20 % protein, 25‑35 % fat; avoid excessive animal protein.
6. Regular medical review – Annual kidney‑stone risk assessment for chronic supplement users.

Complications

If left untreated, quercetin‑induced stones can lead to the same complications as other kidney stones:

• Hydronephrosis – Swelling of the kidney due to urine blockage, potentially causing permanent renal damage.
• Urinary tract infection (UTI) – Stagnant urine promotes bacterial growth; can progress to pyelonephritis.
• Sepsis – Rare but life‑threatening; risk rises with obstructive infection.
• Chronic kidney disease (CKD) – Repeated obstruction and infection may reduce glomerular filtration rate over years.
• Recurrent stone formation – Without addressing the underlying quercetin exposure, the cycle repeats.

When to Seek Emergency Care

---

Sources: Mayo Clinic, National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), World Health Organization (WHO), Cleveland Clinic, Kidney International 2022; Urology International 2023; case series “Quercetin‑related Nephrolithiasis” – Journal of Clinical Urology 2024. All links accessed April 2026.

```